Hi, do you all plan on remaining an LLC for tax purposes, and do you anticipate becoming profitable within the near future?

Hello Lucas and thanks for inquiring. We do anticipate converting to a Corporation within the next 12-15 months and prior to the SAFE converting to equity. In terms of profitability, perhaps it is important to note that we are hoping to attract investors who also happen to use either sildenafil or tadalafil. Part of our marketing message is "why buy from anyone else if you can buy from yourself.....and cheaper"! If we are successful in this messaging, and considering our incredibly low fixed ...

How is this better than companies that have already been doing this for over 10 years for a valuation of 30M? How would you beat out your competitors since anyone can really do this

Thanks for you inquiry Patrick. I think it's important to understand that a HIPAA compliant telehealth site is not like a typical retail site, perhaps for golf balls, that you might find online. The complexity of coordinating a licensed provider network for the purposes of getting a legal prescription and then establishing a nationwide distribution network for those prescriptions is a huge multi-year undertaking. One of the advantages that we have over those competitors who have been in the g...

How do you compete with everyone who has medical insurance. If I wanted ED meds it would cost me $5.00.

Good afternoon Mr Gessner and thank you for your inquiry. If you are one of the few, and I do mean few, fortunate people to have coverage for "lifestyle" meds within your health plan, simply put, we can't. My experience however, after 12 years in the health insurance business and decades in retail pharmacy, is that the overwhelming majority of health plans DO NOT COVER meds such as Sildenafil and Tadalafil. Most beneficiaries don't realize that until the pay a physician office visit copay and...

What is the end state or exit? Acquisition? Pay dividends?

Good afternoon Craig and thanks for your inquiry. At this point I would say that the most likely exit scenario is an acquisition. We believe that once the proverbial "big boys" (Roman, HIMS, RexMD, etc) realize that we can do exactly what they do at a much lower price point, at least in terms of ED medication, they may want to eliminate a low-cost producer. We already have integrated nationwide prescription distribution capability with scalability that HIMS is trying to build out as I type......

Really interesting presentation ... I have invested but I am a supply chain consutlant and you will need me to help with order management, warehousing and distribution as you scale!

Good afternoon Antony and thank you for placing your trust in our team to work for you as an investor! I'm not sure how much insight into our prescription distribution channel you were able to extract from our video, but that is actually one of our greatest competitive strengths as we start to grow. Our fulfillment partner and its affiliated companies currently fill over 16 million prescriptions annually, and most of those are out of their existing 250,000+s.f. facility in Pennsylvania. Shoul...

myEDmeds Updates, Team, and Funding Progress | Wefunder, Home of the Community Round

1

Doctors and pharmacy fulfillment partner licensed and certified in all 50 states and D.C.

2

Long-term deal with industry-leading fulfillment partner ensuring reliable and scalable distribution.

3

$540K prior investor base includes several prominent, experienced business leaders.

4

Huge opportunity in the growing $3.8 billion dollar Erectile Dysfunction medication market.

5

Founded, owned and led by pharmacy professionals with more than 60 years combined experience.

6

Poised to capitalize on the explosive growth of telemedicine by becoming a full telehealth platform.

7

Investors that are also ED medication users won't pay more than $1 per pill for ED meds.

8

Ambassador/affiliate program to potentially yield investment income during growth phase of company.

myEDmeds

We're a nationwide low-cost platform for online Erectile Dysfunction medication

$63,725

Highlights

Team

Memo

myEDmeds

Quick facts

Team profiles

Featured investor profiles

$63,725

Highlights

Related company links

Team

Memo